FDA Inspection 1065807 — Noraxon USA, Inc.

Noraxon USA, Inc. — FEI 2084126

The FDA completed an inspection of Noraxon USA, Inc. on Sep 11, 2018 in Scottsdale, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 11, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Scottsdale, AZ (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures